Overview

Safety and Efficacy Pilot Study of AzaSiteĀ® for Four Weeks in Subjects With Blepharitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and efficacy of AzaSiteĀ® ophthalmic solution, 1% on signs and symptoms of blepharitis.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Azithromycin
Ophthalmic Solutions
Criteria
Inclusion Criteria:

- diagnosis of moderate to severe chronic posterior blepharitis

- If female of childbearing potential, are non-pregnant and non-lactating

Exclusion Criteria:

- had ocular surface surgery (LASIK, refractive, pterygium) within the past year

- unwilling to discontinue use of contact lenses during the study

- have glaucoma

- unable or unwilling to withhold the use of eyelid scrubs during the study

- have a serious systemic disease or uncontrolled medical condition that in the judgment
of the investigator could confound study assessments or limit compliance

- currently using any preserved topical ocular medications (with the exception of
unpreserved tear substitutes) at the time of entry into the study or during study
participation